Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Research Article - Biomedical Research (2017) Volume 28, Issue 14

CGRP modulates the pathogenetic process of psoriasis via promoting CCL27 secretion in a MAPK- and NF-κB signaling pathway-dependent manner

Background: Psoriasis is a chronic inflammatory skin disease that affects up to 4% of the world population, but the mechanism underlying its pathogenesis remains to be unrevealed. Herein we examined the effects of Calcitonin Gene-Related Peptide (CGRP) on an immortal human keratinocyte line HaCaT, thereby revealing the important role of CGRP in the pathogenesis of psoriasis.

Material and Methods: Upon CGRP stimulation the chemotactic capacity of HaCaT cells was evaluated in the presence of CGRP receptor antagonist and a specific p38-MAPK pathway inhibitor, respectively. Quantitative real-time PCR and ELISA were also conducted to examine the secretion of chemotactic cytokines ligand 27 (CCL27) by HaCaT cells. Furthermore, the phosphorylation status of p38 and ERK1/2, and IκBα level were detected by immunoblotting to assess the activity of MAPK and NF-κB pathways.

Results: CGRP increased CCL27 production and promoted HaCaT cell chemotactic ability in vitro, whereas pre-treatment with SB203580 or CGRP8-37 was able to reduce CGRP-enhanced chemotaxis of HaCaT cells and CCL27 production, with inactivation of p38-MAPK and NF-κB pathways.

Conclusion: CGRP can promote the bioactivities of HaCaT cells via a p38-dependent and NF-κBdependent pathway, whose blockage may contribute to further clinical psoriatic treatment.

Author(s): Gui-lian Ye, Xiu-Zhen Ren, Li-guo Qi, Li-xiang Wang, You-can Zhang

Abstract Full Text PDF

Get the App